We recently provided a significant advance in the field by identifying a functional membrane receptor for progranulin, EphA2 [23], and later demonstrated that the progranulin/EphA2 is a critical oncogenic axis in bladder cancer [24]. This evidence concerns the gene GRN and urinary bladder carcinoma.